Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Nordic Pill AB
AB
Active
Org 5591846091
Åkerivägen 17 A, 241 38
Eslöv
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 2018 · 7 years old
4 employees
Monitor
Share
Sweden
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Nordic Pill AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
105M
78M
52M
26M
0M
2021: 19M
19M
2021
2022: 24M (+26% vs 2021)
24M
+26%
2022
2023: 66M (+175% vs 2022)
66M
+175%
2023
2024: 84M (+27% vs 2023)
84M
+27%
2024
2025: 64M (-24% vs 2024)
64M
-24%
2025
EBITDA
SEK millions
10M
7M
5M
2M
0M
2021: 2M
2M
2021
2022: 3M (+50% vs 2021)
3M
+50%
2022
2023: 6M (+100% vs 2022)
6M
+100%
2023
2024: 8M (+33% vs 2023)
8M
+33%
2024
2025: 7M (-12% vs 2024)
7M
-12%
2025
Income statement
SEK thousands
Item
2025
2024
2023
2022
2021
Revenue
64 457
83 843
65 543
24 463
19 157
Staff expenses
−3 332
—
−841
−650
—
EBITDA
6 731
8 366
5 955
3 214
1 553
Depreciation & amort.
−160
−46
−37
−25
−20
EBIT
6 570
8 320
5 917
3 190
1 533
Net financials
−28
166
62
−15
21
Profit before tax
1 398
6 336
4 479
2 379
1 163
Tax
−320
−1 334
−934
−500
−243
Net profit
1 079
5 002
3 545
1 879
920
Balance sheet
SEK thousands
Item
2025
2024
2023
2022
2021
Total assets
31 567
40 348
34 485
9 015
5 385
Equity
12 665
11 586
6 585
4 089
2 211
Long-term debt
475
0
—
—
0
Short-term debt
13 481
23 816
25 106
3 631
2 675
Total debt
13 957
23 816
25 106
3 631
2 675
Financial ratios
5-year trend
EBITDA margin
10,4 %
This company
15,8 %
Market median
This company
Market median
34% below market
2021
2025
Equity ratio
40,1 %
This company
38,2 %
Market median
This company
Market median
5% above market
2021
2025
Return on equity
8,5 %
This company
18,4 %
Market median
This company
Market median
54% below market
2021
2025
Net profit margin
1,7 %
This company
8,1 %
Market median
This company
Market median
79% below market
2021
2025
Asset turnover
2,04×
This company
1,12×
Market median
This company
Market median
82% above market
2021
2025
Debt / equity
1,49×
This company
0,62×
Market median
This company
Market median
140% above market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
More on Nordic Pill AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
